Larvol Delta - BFMNN112-Phase-2-Trial-of-BMF219-in-Participants-With-Type-1-Diabetes-Mellitus

icovamenib (BMF-219) - Biomea Fusion

http://clinicaltrials.gov/ct2/show/NCT06152042

Sep 11, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next